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It is widely accepted that reactive oxygen species (ROS)
promote tumorigenesis. However, the exact mechanisms
are still unclear. As mice lacking the peroxidase peroxir-
edoxin1 (Prdx1) produce more cellular ROS and die
prematurely of cancer, they offer an ideal model system
to study ROS-induced tumorigenesis. Prdx1 ablation in-
creased the susceptibility to Ras-induced breast cancer.
We, therefore, investigated the role of Prdx1 in regulating
oncogenic Ras effector pathways. We found Akt hyperac-
tive in ﬁbroblasts and mammary epithelial cells lacking
Prdx1. Investigating the nature of such elevated Akt
activation established a novel role for Prdx1 as a safeguard
for the lipid phosphatase activity of PTEN, which is essen-
tial for its tumour suppressive function. We found binding
of the peroxidase Prdx1 to PTEN essential for protecting
PTEN from oxidation-induced inactivation. Along those
lines, Prdx1 tumour suppression of Ras- or ErbB-2-induced
transformation was mediated mainly via PTEN.
The EMBO Journal (2009) 28, 1505–1517. doi:10.1038/
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Keywords: oxidative stress; peroxiredoxin1; PTEN phospha-
tase; transformation; tumour initiation
Introduction
Peroxiredoxins (Prdxs) are a superfamily of small non-seleno
peroxidases (22–27kDa) currently known to possess six
mammalian isoforms. Although their individual roles in
cellular redox regulation and antioxidant protection are
quite distinct, they all catalyse peroxide reduction to balance
cellular H2O2 levels essential for signalling and metabolism
(Rhee, 2006). Prdxs I–IV share the common CxxC motif and
use thioredoxin (Trx) as an electron donor (Chae et al,
1994a). On reaction with peroxides, the Prdxs’ ‘peroxidatic’
cysteine (Cys51 in Prdx1) is oxidized into a sulfenic acid
intermediate, which then forms a disulﬁde bond with the
‘resolving’ cysteine (Cys172 in Prdx1) from the other homo-
dimer’s subunit. Catalytic reduction of peroxides results in
different oxidation states of the catalytic cysteine. Lower
oxidation states (sulfenic acid) are reduced back to thiol by
the Trx system. Higher oxidation states such as sulﬁnic acid
can be reduced back to thiol by sulﬁredoxin, whereas the
oxidation to sulfonic acid is irreversible and results in Prdx
degradation (Neumann and Fang, 2007). Loss of Prdx1 short-
ens the life span of mice due to the development of hemolytic
anemia and cancer. Analysis of cells and mice lacking Prdx1
suggested that it not only regulated H2O2 levels, but also that
it possessed the properties of a tumour suppressor (Neumann
et al, 2003), which was further supported by the ﬁnding that
Prdx1 interacts with c-Myc thereby selectively inhibiting
c-Myc transcriptional activity (Egler et al, 2005).
Peroxides are known to modify protein tyrosine phospha-
tases (PTPs) by oxidation. PTP catalytic property depends on
a thiolate anion of a low pKa cysteine residue (pKa 4.7–5.4)
located in the conserved motif of its active site (Zhang and
Dixon, 1993; Peters et al, 1998). This highly nucleophilic
group makes the initial attack on the phosphate group of the
substrate, but renders the PTP extremely susceptible to
oxidation resulting in its inactivation. The PTP and tumour
suppressor PTEN exhibits phosphatase activity towards phos-
phoinositides and tyrosine phosphates and is known to be
inactivated through H2O2-mediated oxidation or through
growth factor signalling, including epithelial growth factor
(EGF) or platelet-derived growth factor (PDGF) (Leslie et al,
2003; Kwon et al, 2004). Analysis of human recombinant
PTEN revealed that two of the ﬁve cysteines in its N-terminal
phosphatase domain (PTD) (Cys71 and Cys124) form a
disulﬁde bond after oxidation, which resulted in the transient
inhibition of its phosphatase activity and allowed oxidized
PTEN to migrate faster on a non-reducing SDS–PAGE (Lee
et al, 2002; Kwon et al, 2004). In stimulated macrophages,
PTEN oxidation led to the temporary inhibition of its phos-
phatase activity and in the phosphorylation of Akt on Serine
473 (Leslie et al, 2003).
PTEN deﬁciency is a hallmark of many human tumours
(Keniry and Parsons, 2008) and is accompanied by enhanced
cell proliferation, decreased cell apoptosis and increased Akt
activity (Stambolic et al, 1998). Akt is regulated by PI3K and
PTEN, thus playing a central role particularly in Ras- and
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1505ErbB-2-induced transformation. Akt activity has been proven
crucial for the initiation of this transformation, both in vitro
and in vivo (Sheng et al, 2001; Hutchinson et al, 2004; Lim
and Counter, 2005) and phosphatase inactive PTEN (PTEN
Cys124Ser) is incapable of suppressing Ras-induced transfor-
mation either in vitro or in vivo (Tolkacheva and Chan, 2000;
Koul et al, 2002).
Although it is known that PTEN activity is negatively
regulated through oxidation, the existence of a protective
mechanism inhibiting such inactivation has not been pro-
posed. On the basis of our ﬁndings, we propose here that
Prdx1 promotes PTEN tumour suppressive function by bind-
ing PTEN and protecting its lipid phosphatase activity from
H2O2-induced inactivation. This way, Prdx1 controls exces-
sive cellular Akt activity and reduces the susceptibility to
H-Ras and ErbB-2-induced transformation.
Results
Prdx1 inhibits Ras-induced transformation through
its peroxidase activity
We tested ﬁrst Prdx1 peroxidase activity under physiological
conditions and measured endogenous H2O2 release in
growing cells over time. Extracellular H2O2 buildup from
Prdx1
 / ;Prdx1WTMEFs was less compared with Prdx1
 / 
MEFs during the 240min measured. In contrast,
Prdx1
 / ;Prdx1C51/172SMEFs resulted in an excess of extracel-
lular H2O2 buildup (Supplementary Figure S1A). Rates
calculated for extracellular H2O2 buildup (pmol/min) con-
ﬁrmed that Prdx1
 / ;Prdx1WTMEFs released H2O2 at a 30%
lower rate than Prdx1
 / MEFs, whereas Prdx1
 / ;Cys51/172S
MEFs released H2O2-release 1.5-fold more than Prdx1
 / 
MEFs (Figure 1A, left panel). Western blotting analysis
further conﬁrmed that Prdx1 was functioning as a peroxidase,
as Prdx1
WT protein formed mostly DTT-reducible (data not
shown) H2O2-scavenging dimeric structures (Figure 1A, right
panel), whereas Prdx1
Cys51/172S did not, as dimer formation
depends on Cys51 and Cys172 disulﬁdes (Chae et al, 1994b).
The remaining Prdx1 monomers were not over-oxidized and
therefore active (unlike Prdx1 monomers in H2O2-treated
Prdx1
 / ;Prdx1WTMEFs). Prdx1 peroxidase activity was
required to suppress H-Ras-induced tumour suppression, as
Prdx1
 / MEFs transduced with retrovirus expressing
H-Ras
V12 formed two-fold more colonies in soft agar com-
pared with Prdx1
þ/þ;H RasV12MEFs (Figure 1B, left panel).
Expression of exogenous Prdx1
WT reduced colony formation
by 50% in Prdx1
 / ;H RasV12MEFs and by 20% in
Prdx1
þ/þ;H RasV12MEFs, whereas exogenously expressed
Prdx1
C51/172S modestly increased colony formation in
Prdx1
 / ;H RasV12MEFs and Prdx1
þ/þ;H RasV12MEFs.
Western blot analysis ensured that re-expression of Prdx1
proteins in Prdx1
 / MEFs did not exceed those Prdx1 levels
found in Prdx1
þ/þMEFs (Figure 1B, right panel).
Prdx1
 / ;H RasV12MEFs appeared also more spindle-like
than Prdx1
þ/þ;H RasV12MEFs, whereas expression of
Prdx1
WT in Prdx1
 / ;H RasV12MEFs reversed the spindle-like
morphology. Expression of exogenous Prdx1
C51/172S,
however, promoted spindle-like cell morphology in both
Prdx1
 / ;H RasV12MEFs and Prdx1
þ/þ;H RasV12MEFs
(Supplementary Figure S1B). Analysis of the Prdx1 peroxi-
dase activity in H-Ras
V12-transformed MEFs showed that
Prdx1
 / ;Prdx1WT;H RasV12MEFs released H2O2 at a 26%
lesser rate than Prdx1
 / ;H RasV12MEFs, which was compar-
able to the rate found Prdx1
 / EVMEFs. In contrast,
Prdx1
 / ;C51/172S;H RasV12MEFs had a 1.5-fold increased rate
of H2O2 release compared with Prdx1
 / ;Prdx1WT;H RasV12MEFs
(Figure 1C).
Loss of Prdx1 promotes PTEN oxidation and Akt
activation
We investigated now whether Prdx1 regulates H-Ras effector
pathways known to promote transformation, including PI3K/
Akt, RalGEF or MAPK pathways (Li et al, 2004; Lim and
Counter, 2005). Treatment of MEFs with H2O2 (50mM) for
increasing periods of time enhanced Akt phosphorylation on
Ser473 (pAkt
Ser473) and Thr308 (pAkt
Thr308) at a higher
level in Prdx1
 / MEFs compared with Prdx1
þ/þMEFs
(Figure 2A). This ﬁnding correlated with a steady increase
of PTEN oxidation over time in Prdx1
 / MEFs, whereas in
Prdx1
þ/þMEFs PTEN oxidation plateaued after 6–8min
(Figure 2B and C). Phosphorylation of Akt on serine 473
(pAkt
Ser473) and PTEN oxidation increased also in Prdx1
 / 
MEFs compared with Prdx1
þ/þMEFs when exposed to in-
creasing amounts of H2O2 (Supplementary Figure S2A and
B). Similar data were obtained by inducing H2O2 endogen-
ously through treating cells with PDGF, as it led to a
larger increase in (1) pAkt
Ser473 and pAkt
Thr308 (Figure 2D)
and (2) PTEN oxidation in Prdx1
 / MEFs when compared
with Prdx1
þ/þMEFs (Figure 2E). Although PTEN oxidation
steadily increased in Prdx1
 / MEFs, it decreased in Prdx1
þ/þ
MEFs over time (Figure 2E and F). Levels of PAkt
Ser473 and
PTEN oxidation was also increased in Prdx1
 / MEFs com-
pared with Prdx1
þ/þMEFs when exposed to increasing
amounts of H2O2 or PDGF (Supplementary Figure S2A–D).
Lastly, we conﬁrmed that lack of Prdx1 enhanced basal and
H2O2-induced phosphorylation of Akt substrates in Prdx1
 / 
MEFs more than in Prdx1
þ/þMEFs (Figure 2G).
Prdx1 interacts with PTEN
PTEN forms a complex with endogenous and epitope-tagged
HA–Prdx1 (Figure 3A). This complex was regulated by
oxidative stress, as co-expressed epitope-tagged Myc–PTEN
and HA–Prdx1 dissociated under increasing concentrations
of oxidative stress (Figure 3B, upper panel). In contrast,
increasing dosages of H2O2 did not disrupt binding of
Prdx1
Cys51/72Ser with PTEN (Figure 3C). Immunoblotting
conﬁrmed equal expression of proteins (Supplementary
Figure S3A and B). Peroxidatic Cys51 may regulate the
H2O2-induced Prdx1:PTEN complex disruption as Prdx1
C51S
and Prdx1
C51/172S proteins bind more to wild-type PTEN
than Prdx1
C172S (Figure 3D). We further conﬁrmed a physical
association between Prdx1 and PTEN by using GST-pull down
of GST–Prdx1 and His–PTEN (Figure 3E). Mutational analysis
suggested that Prdx1 interacts within the C2 domain of PTEN
(amino acids 186–274) (Figure 3F; Supplementary Figure S3C
and D) and PTEN with the N terminus of Prdx1 (amino acids
1–40) and the C terminus of Prdx1 (amino acids 157–199)
(Figure 3F, lower schematic and Supplementary Figure S3G).
Computational analysis allowed us to narrow those interac-
tion surfaces (Figure 3G). The images of Prdx1 and PTEN
were generated from coordinates from the protein database
1d5r (Lee et al, 1999) and 2z9s (Matsumura et al, 2008),
respectively. As shown for PTEN, the region of 186–251
consists of two double-stranded anti-parallel sheets con-
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of Prdx1 consists of a single double-stranded anti-parallel
sheet and another, surface exposed single sheet strand. In
Figure 3G, the Prdx-1 protein is shown only as the monomer
and the helical region that lies at the dimer interface, residues
183–199, are also positioned in a surface exposed position
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Figure 1 (A) Left panel: rate of H2O2 release per minute was analysed by calculating the linear slope of data obtained in Supplementary Figure
S1A. H2O2 release is expressed per 1 10
6 cells per minute. P-values were calculated using an unpaired Student’s t-test. Rate of H2O2 release in
Prdx1
 / MEFs compared with either Prdx1
 / Prdx1WTMEFs (*P¼0.04) or Prdx1
 / Prdx1Cys51/172S (**P¼0.001). Right panel: protein levels and
oxidation status of expressed Prdx1 in MEFs used in left panel. Protein lysates were prepared as described under Materials and methods and
analysed under non-reducing conditions. Status of over-oxidized Prdx1 was tested by using an antibody recognizing Prdx1 (Prdx1-SO2/SO3)
(Woo et al, 2003). (B) Left panel: Prdx1
 / MEFs and Prdx1
þ/þMEFs were infected with retroviral constructs carrying genes for Prdx1
WTor
Prdx1
C51/172S. MEFs were further infected with retrovirus expressing either H-Ras
V12 or puromycin resistance gene only (EV) and plated in
duplicates in soft agar. Colonies were counted after 18–20 days. Right panel: proteins of clones used in soft agar experiment were analysed for
expression levels of Prdx1 and Ras. (C)R a t eo fH 2O2 release per minute was analysed by calculating the linear slope of MEFs used in (B, left
panel). For each clone, six wells were plated and analysed. The experiment shown here is representative of three independent studies from two
different sets of MEF clones obtained from Prdx1 littermates. P-values were calculated using an unpaired Student’s t-test. *P¼0.045;
**P¼0.004. Differences in Prdx1
þ/þMEFs were not statistically signiﬁcant.
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interaction. Deleting the identiﬁed interaction sites in
PTEN and Prdx1 altered enzyme activity of both enzymes
(data not shown), which did not allow us to study the role of
a physical interaction in protecting PTEN lipid phosphatase
activity.
Prdx1 interaction with PTEN protects and promotes
PTEN lipid phosphates activity under oxidative stress
PTEN lipid phosphatase activity was fully protected by Prdx1
in cells under mild oxidative stress (25mMH 2O2) (Figure 4A),
where Prdx1 was found to bind PTEN (Figure 3B). However,
under higher oxidative stress treatment (500mMH 2O2),
which resulted in decreased binding of PTEN and Prdx1
(Figure 3B), impaired PTEN’s lipid phosphatase activity.
Western blotting conﬁrmed equal amounts of PTEN protein
in the lipid phosphatase assay (Figure 4A, lower panel).
To complement those results, we exposed recombinant
puriﬁed His-tagged PTEN to H2O2 in the absence or presence
of increasing amounts of puriﬁed recombinant Prdx1 and
assayed PTEN for PI(3,4,5)P3 utilization. As expected
(Figure 4B), in the presence of H2O2, we found that low
molar amounts of Prdx1 protein weakly protected PTEN lipid
phosphatase activity, whereas equimolar Prdx1 fully restored
and further increases in Prdx1 protein amount did not
enhance PTEN lipid phosphatase activity any more. Pre-
incubation of PTEN in this assay with N-and C-terminal
Prdx1 peptide replica (P1 and P2, respectively; peptide se-
quences were based on Prdx1 interaction mapping as shown
in Supplementary Figure S3G and discussed for Figure 3G)
decreased PTEN lipid phosphatase activity efﬁciently to 53%,
which was comparable to PTEN activity observed with H2O2
treatment in the absence of Prdx1 (50%) (Figure 4C).
Addition of P1 decreased PTEN lipid phosphatase activity
only to 65%, whereas P2 lowered it to 57%. However, as
shown in Figure 4D, the addition of His-puriﬁed PTEN to
recombinant Prdx1 inhibited Prdx1 peroxidase activity.
Under our experimental conditions, the kinetics of NADPH
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Figure 2 (A) Prdx1
 / MEFs and Prdx1
þ/þMEFs were stimulated with H2O2 as indicated. Protein lysates were collected under argonized
conditions by scraping cells into argon-purged lysis buffer (see Materials and methods) and analysed under non-reducing conditions on SDS–
PAGE. Akt phosphorylation was detected on Ser473 and Thr308. Akt protein as loading control. (B) Prdx1
 / MEFs and Prdx1
þ/þMEFs protein
lysates were treated as described under (A) and analysed for oxidized PTEN proteins. Actin as loading control. (C) Levels of oxidized PTEN
proteins were evaluated by quantifying oxidized and reduced PTEN using a Fuji imaging system (LAS 3000) and related software
(ImageGuage). Quantiﬁcations of staining intensities were obtained by analysing protein bands from the same ECL obtained ﬁlm exposure.
The y-axis represents staining intensities in arbitrary units of oxidized PTEN. Curves represent data from three independent experiments.
(D) Prdx1
 / MEFs and Prdx1
þ/þMEFs were stimulated with PDGF as indicated. Protein lysates were collected and analysed as described
under (A). (E) Prdx1
 / MEFs and Prdx1
þ/þMEFs protein lysates were treated as described under (D) and analysed for oxidized PTEN
proteins. Actin as loading control. (F) Data analysis was done as described under (C). All experiments shown are representative of at least three
independent studies including two sets of MEF clones from Prdx1 littermates. (G) Serum starved MEFs were stimulated with H2O2 as indicated.
Protein lysates were collected and analysed as described under (A). Akt substrates were detected by western blotting using an phospho-Akt
substrate antibody (RXRXXS/T).
Prdx1 regulates Akt activity via PTEN
J Cao et al
The EMBO Journal VOL 28 | NO 10 | 2009 &2009 European Molecular Biology Organization 1508Endog–Prdx1SO2/O3
HA–IP
Myc–PTEN
IgG  heavy chain
HA–Prdx1SO2/O3
Myc–PTEN 
HA–Prdx1   
H2O2 (μ μM) 0 0 25 50 100 250 500
Endog–Prdx1
HA–Prdx1
A B
HA–Prdx1C51/172S
Endog–Prdx1SO2/O3
Myc–PTEN
Myc–PTEN 
HA–Prdx1 C51/172S 
H2O2 (μM) 0 25   50  100    250 500
HA–IP
Endog–Prdx1
C
HA–Prdx1 ––+
PTEN
HA–Prdx1
Endog–Prdx1
PTEN–IP IgG–IP
D
E
GST–EV
His-PTEN
GST–Prdx1
Input
Pull down
F
PTEN Prdx1
*
G
Cys172/51S
Cys51S
Cys172S
WT
Cys172/51S
Cys51S
Cys172S
WT
HA–IP Lysate
HA–Prdx1
Endog–Prdx1
PTEN
Potential PTEN
interaction site
Potential PTEN
interaction site
186 351
PTP C2 tail
C124 1
PBD
274
Potential Prdx1
interaction sites
PTEN
Prdx1
C51 C172 21 1 199
403
Figure 3 (A) Epitope-tagged PTEN was expressed in 293Tcells. Cell lysate was prepared under anaerobic conditions and immunoprecipitates
were prepared as described in Materials and methods. A measure of 1000mg of protein was immunoprecipitated (anti-PTEN antibody; Santa
Cruz). Proteins were analysed by SDS–PAGE. PTEN and Prdx1 proteins were detected by staining membranes with anti-PTEN (138G6, Cell
Signaling) and anti-Prdx1 (Abcam) antibodies, respectively. (B) Epitope-tagged PTEN and Prdx1 wild type were co-expressed in 293T cells.
Before lysis, cells were treated with increasing dosages of H2O2 as indicated for 15min. Cell lysates were prepared under anaerobic conditions,
and precipitated over night using HA-conjugated agarose beads. IPs were washed four times with argon-purged lysis buffer and analysed by
western blotting. Proteins were detected with anti-PTEN, anti-Prdx1-SO2/-SO3 and anti-Prdx1 antibodies. Epitope-tagged Prdx1 migrates slower
electrophoretically than endogenous Prdx1, labelled as HA–Prdx1. Epitope-tagged PTEN is labelled as Myc–PTEN. Anti-Prdx1-SO2/-SO3 can
cross-react with Prdx2-4 and stains more intense in the IP proteins due to over night incubation and longer exposure to atmospheric oxygen.
In contrast, lysates were immediately frozen (Supplementary Figure S3A and B). (C) Myc–PTEN and HA–Prdx1
C51/172S were analysed as
described under (B). Anti-Prdx1-SO2/-SO3 does not bind Prdx1
C51/172S.( D) Recombinant His–PTEN (100nM) was applied to equimolar GSTor
GST–Prdx1 and incubated over night. Glutathione sepharose (GST) beads were added for GST-pull down and analysed by western blotting.
Input represents 1/50 of the total. (E) HA–Prdx1 wild type and cysteine to serine mutants of catalytically active Prdx1 cysteines were co-
expressed with Myc-tagged PTEN wild type. HA–IPs were processed as under (B). Left side shows co-immunoprecipitations, right side shows
expression of PTEN and Prdx1 cysteine to serine mutants. (F) Schematic domain structure of potential interaction sites of Prdx1 with PTEN
(upper schematic) and PTEN with Prdx (lower schematic). (G) Identiﬁcation of potential interaction sites using computer modelling (SwissPdb
Viewer version 4; http://www.expasy.org/spdbv) (Guex and Peitsch, 1997). *Prdx1 N terminus.
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þ were linear and the Prdx1 inhibition
was proportional to molar amount of PTEN and reached
saturation (completed inhibition) at PTEN/Prdx1¼1:1
(mol/mol) ratio. Moreover, an increase in PTEN ratio lowered
the velocity of Prdx1 peroxidase activity (Figure 4E).
Prdx1 suppresses H-Ras and ErbB-2-induced
transformation mainly via promoting PTEN activity
Next, we examined in PTEN
 / MEFs whether Prdx1 has an
important function in PTEN-induced tumour suppression.
Although Prdx1 knock down in PTEN
 / MEFs decreased
A
C
DE
B
Figure 4 (A) Epitope-tagged Myc–PTEN and HA–Prdx1 were co-expressed in 293T cells, which were treated with H2O2 for 15min, as
indicated. Cell lysates were prepared under anaerobic conditions, and precipitated over night as described above by using anti-PTEN antibody.
PTEN-immunoprecipitates were analysed for PI(3,4,5)P3-utilization in a 96-well plate assay as described in Materials and methods (triplicate
samples). All results are presented as mean±s.e. (or difference) for at least two independent experiments. Equal PTEN protein amount was
conﬁrmed by western blotting. (B) 500mMo fH 2O2 was added to either 20pmoles of recombinant His-puriﬁed PTEN in the presence of different
amounts of recombinant puriﬁed Prdx1 as indicated and described in Materials and methods. Experiment shown is representative of three
independent studies. (C) PTEN activity was measured as described in (B) in the presence of peptides interfering with Prdx1 binding to PTEN.
P1 (peptide 1) is replica of ﬁrst N-terminal 21 amino acids (AS) of Prdx1; P1 Sc, scrambled sequence of P1; P2 (peptide 2), replica of last C-
terminal 26 AS of Prdx1; P2 Sc, scrambled sequence of P2. The results are presented as mean±s.e. (or difference) for at least two independent
experiments. (D) Prdx1 peroxidase activity was measured by a standard thioredoxin (Trx)/thioredoxin reductase (TrxR)/NADPH-coupled
spectrophotometric assay (see Materials and methods for details). A measure of 20pmoles of puriﬁed Prdx1 (Sigma) was incubated with
500mMH 2O2 and increasing molar amounts of puriﬁed His–PTEN as indicated. Prdx1 peroxidase activity (without PTEN) was about 68nmol/
mg protein/min under those conditions (extinction coefﬁcient 6.62mM
 1cm
 1 for NADPH at 340nm). Experiment shown is representative of
three to four independent studies. (E) Relative reaction velocity of Prdx1 peroxidase activity from (D) was determined by plotting linear
regression coefﬁcient K (y¼a Kx, where y is the absorbency at 340nm and x is time) versus various PTEN/Prdx1 (mol/mol) ratios. The
results are presented as mean±s.e. (or difference) for at least two independent experiments.
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Ser473 levels, H2O2 treatment of MEFs increased it equally
in PTEN
 / MEFs and PTEN
þ/þMEFs (Figure 5A). Prdx1 is
neither over-oxidized nor does it form less peroxidase active
dimers in PTEN
 / MEFs compared with PTEN
 / MEFs re-
constituted with GFP–PTEN, suggesting that in PTEN-null
cells, Prdx1 activity is not compromised after H2O2 treatment
(Figure 5B). PI3K/Akt signalling is also essential for onco-
genic ErbB-2-induced transformation (Maroulakou et al,
2007), and Akt1 deﬁciency sufﬁciently suppresses tumour
development in PTEN
þ/ mice (Chen et al, 2006). As shown
for H-Ras (Figure 1B), Prdx1
WT also prevented ErbB-2/neuT-
induced transformation depending on its peroxidase activity
(Supplementary Figure S5A). By using small hairpin (sh)
RNA targeting Prdx1 mRNA (shPrdx1) in PTEN
 / MEFs,
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Figure 5 (A) PTEN
 / MEFs were serum starved for 48h and treated with H2O2 as indicated for 10min. Protein lysates were analysed for
pAkt
Ser473 as described before. (B) PTEN
 / MEFs were infected with retrovirus expressing GFP–PTEN. After 5-day selection in puromycin
(2mg/ml), MEFs were serum starved, exposed for 10min to H2O2 and analysed for Prdx1 oxidation and formation of dimeric structures by non-
reducing SDS–PAGE. *Prdx1 hetero-dimer formation with other Prdxs. (C) PTEN
 / MEFs were infected with retrovirus expressing shPrdx1,
GFP–PTEN, H-Ras
V12 or various vectors carrying resistance gene only (pBabe, pMKO1). MEFs were plated in soft agar. Colonies were counted
after 21 days. *Po0.001 (Student’s t-test). (D) As under C, except MEFs express ErbB-2/neuT instead of H-ras
V12.* * Po0.039 (Student’s t-test).
(E) Immunoblotting of MEFs from (C and D).
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showed that Prdx1 suppressed transformation mainly by
regulating PTEN (Figure 5C–E). Although shPrdx1 expressed
in PTEN
 / ;H RasV12MEFs or PTEN
 / ;ErbB 2/neuT MEFs
did not increase colony formation compared with
PTEN
 / ;H Ras;pMKO1MEFs or PTEN
 / ErbB 2/neuT;pMKO1
MEFs, in PTEN
 / ;shPrdx1;GFP PTEN,H RasV12MEFs showed
1.5-fold increase in colony formation compared with
PTEN
 / ;pMKO1;GFP PTEN,H RasV12MEFs and PTEN
 / ;shPrdx1;
GFP PTEN,ErbB 2/neuTMEFs and 1.35-fold increase in colony
formation compared with PTEN
 / ;pKMO1;GFP PTEN;
ErbB 2/neuTMEFs. Furthermore, a slight increase of Prdx1
oxidation was noted in PTEN
 / ;pMKO1;H RasV12MEFs
compared with PTEN
 / ;GFP PTEN;H RasV12MEFs and
in PTEN
 / ;pMKO1;ErbB 2/neuTMEFs compared with
PTEN
 / ;GFP PTEN;ErbB 2/neuTMEFs. By using minimum
dosages of two well-known PI3K inhibitors, Wortmannin
(WM) and Ly294002 (Ly) that inhibited H2O2-induced Akt
activity in Prdx1
 / MEFs less efﬁciently than in Prdx1
þ/þ
MEFs (Supplementary Figure S5B), we found that partial
inhibition of PI3K/Akt activity translates into less efﬁcient
inhibition of H-Ras or ErbB-2-induced transformation in
Prdx1
 / MEFs compared with Prdx1
þ/þMEFs (Table I):
5nM WM reduced Prdx1
 / ;H RasV12MEFs colony number
by o4%, 10nM WM by 2.3%. However, 5nM WM decreased
Prdx1
þ/þ;H RasV12MEFs colony numbers by 46% and
(P¼o0.001) 10nM WM by 67%. Similarly, 10mML y
decreased Prdx1
 / ;H RasV21MEFs colony number by 61%
and in Prdx1
þ/þ;H RasV12MEFs by 73%. However, 10mML y
decreased colony number of Prdx1
 / ;ErbB 2/neuTMEFs by
only 53%, whereas in Prdx1
þ/þ;ErbB 2/neuTMEFs by 75%.
Moreover, 25mM Ly decreased colony formation equally
in Prdx1
 / ;ErbB 2/neuTMEFs and Prdx1
þ/þ;ErbB 2/neuTMEFs
to 4–5%.
Loss of Prdx1 promotes H-Ras-induced mammary
tumours and PTEN oxidation in mammary
epithelial cells
MMTV/v-H-Ras mice transgenic mice are highly susceptible
to mammary carcinomas due to the targeted over-expression
of the activated Ras oncogene in their mammary glands (Sinn
et al, 1987) and Akt1 ablation lowers the incidence of
tumours in these mice (Maroulakou et al, 2007). In our
experiment, we conﬁrmed that Prdx1 plays a role in Ras-
induced tumorigenesis in vivo (Figure 6A). In all, 60% of the
Ras/Prdx1
þ/þ mice remained tumour free during the entire
observation period of 36 weeks. In contrast, only 40% of the
Ras/Prdx1
þ/  mice remained tumour free during that time
with a median survival (T50) of 28 weeks, which indicated
that the loss of one copy of Prdx1 accelerated Ras-induced
breast cancer. Moreover, eliminating both copies of Prdx1 in
MMTV/v-H-Ras mice (Ras/Prdx1
 / ), the T50 for breast
cancer was only 20 weeks. We then evaluated basal PTEN
oxidation and pAkt
Ser473 in mammary epithelial cells (MECs)
from 16-week-old mice that had not developed tumours. Lack
of Prdx1 increased basal PTEN oxidation (Figure 6B) and
pAkt
Ser473 (Figure 6C).
Discussion
Compared with Prdxs, catalase peroxidase activity decom-
poses H2O2 with a 41000-fold higher KM (Chae et al, 1994a;
Loewen et al, 2004) and therefore eliminates H2O2 with much
higher efﬁciency. Thus, we cannot expect that Prdx1 sca-
venges H2O2 in considerable amounts, as shown in Figure 1A
and Supplementary Figure S1A. Yet, Prdx1’s peroxidase
activity is important in preventing H-Ras
V12 (Figure 1B) or
ErbB-2/neuT (Supplementary Figure S5A) induced transfor-
mation. Similar to the catalase knockout mice, all other
currently published Prdxs knockout mice, show phenotypi-
cally no increased susceptibility to transformation (Ho et al,
1997). Therefore, Prdx1 may have a unique function amongst
cellular peroxidases in tumour suppression, by affecting
signalling directly through physical interaction with target
enzymes. This was shown for c-Abl tyrosine kinase (Wen and
VanEtten, 1997) and c-Jun terminal kinase (Kim et al, 2006).
As described here for PTEN (Figure 3B), oxidative stress
induced Prdx1 to dissociate, which in case of c-Abl
(Neumann et al, 1998) and JNK (Kim et al, 2006) resulted
in kinase activation. The Prdx1:PTEN heterodimer is most
likely formed in a 1:1 molar ratio, as (1) the Prdx1 preserva-
tion of PTEN lipid phosphatase activity under oxidative stress
is achieved by a 1:1 (mol:mol) ratio of Prdx1 and PTEN and
could not be further increased by excess of Prdx1 (Figure 4B)
and (2) Prdx1
C51/172S, which is unable to form dimeric
structures (Chae et al, 1994b), bound to PTEN and did not
dissociate under H2O2 treatment (Figure 3C). Therefore, these
data provide compelling evidence that Prdx1 may bind PTEN
as a monomer.
We further propose that the Prdx1:PTEN interaction is
essential for protecting PTEN from oxidation-induced
inactivation (Figure 4C), as Prdx1 C- and N-terminal peptide
Table I Prdx1
 / MEFs have a higher sensitivity to PI3K inhibitors in H-Ras or ErbB-2 induced transformation
Wortmannin (nm) H-Ras colony
number in %
Ly294002 (mM) H-Ras colony number in % ErbB-2/neuTcolony number in %
0 Prdx1
 /  100±23.3 0 Prdx1
 /  100±11.2 100±4.6
5 96.3±5.7 10 38.3±15.2 47.3±6.6
10 97.8±13.5 25 5±10.1 3.2±4.1
0 Prdx1
+/+ 100±4.1 0 Prdx1
+/+ 100±11.2 100±4.6
5 55.9±12.5 10 26.3±5.5 25.1±6.6
10 32.7±24.4 25 4±8.7 3.2±4.8
Prdx1
 / MEFs and Prdx1
+/+MEFs were retrovirally infected with constructs carrying genes for H-Ras
V12 or ErbB-2/neuT (ErbB-2Val644Glu)
and treated after plating in soft agar either with 10 or 25mM Ly294002 every 2 days or Wortmannin 5 or 10nM every day. Colonies were counted
after 21 days. Decrease in colony formation (%) relates to untreated of the same genotype (%). This experiment is representative of three
independent studies with two different sets of MEF clones from Prdx1 littermates.
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and computer modelling to block PTEN docking sites on
Prdx1 (Figure 3F and G; Supplementary Figure S3E), resulted
after H2O2 treatment in a 47% reduction of PTEN activity.
This was comparable to PTEN activity after H2O2 treatment in
the absence of Prdx1 (50%) (Figure 4C). The Prdx1 N
terminus, which includes Cys51, may have an important
function in regulating the H2O2-induced dissociation of the
Prdx1:PTEN complex, as Cys51 when replaced by a serine
enhances Prdx1 binding to PTEN (Figure 3D). X-ray crystal-
lography of Prdxs suggested signiﬁcant conformational
changes, such as unwinding of the active site N-terminal
helix, to form disulﬁdes, as in reduced Prdxs, the sulfur
atoms of the N- and C-terminal conserved cysteine residues
are too far apart to react with each other (Schroder et al,
2000; Matsumura et al, 2008). Therefore, in the Prdx1:PTEN
complex, increased H2O2 may oxidize Cys51 (Prdx1), thus,
promoting unwinding of the PTEN-binding conformation of
Prdx1 consequently inducing dissociation.
Over-oxidation of Prdx1 Cys51 occurs during catalysis and
correlates with increasing amounts of Trx (Yang et al, 2002).
The reduction of Cys51 by Trx inhibits the folding back of
Cys51 into its pocket thereby exposing it to further oxidation
by H2O2. The binding of PTEN to Prdx1 could have similar
effects on Prdx1, thereby inhibiting sufﬁcient reduction of
Cys51 by Trx and decreasing Prdx1 peroxidase activity
(Figure 4C and D). Alternatively, as it has been shown that
Trx binds PTEN and inactivates its lipid phosphates activity, it
could be that under our experimental conditions Trx is
depleted from the Prdx1 scavenging system by binding
PTEN (Meuillet et al, 2004). This seems unlikely though, as
Trx was added in approximately 300-fold molar excess, which
should provide a large Trx pool to reduce oxidized Prdx1
proteins.
We deﬁned a novel interaction site of Prdx1 with PTEN in
the C2 domain of PTEN (Figure 3F; Supplementary Figure
S3D and E), which together with the N-terminal PTD, are
both required for enzyme activity. Surface plasmon reso-
nance analysis revealed that the C2 domain is essential for
high-afﬁnity membrane binding of PTEN (Das et al, 2003).
Our data support this ﬁnding, as it has been shown recently
through chemical proteomic strategy using cleavable lipid
baits, that Prdx1 is a potential novel phosphoinositides-bind-
ing protein (Pasquali et al, 2007). Prdx1 may, therefore,
stabilize PTEN binding to the plasma membrane, which in
a recent analysis using single-molecule TIRF microscopy,
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Figure 6 (A) The percentage of mice free of H-Ras-induced mammary tumours is shown in MMTV-v-H-Ras mice carrying only one, none, or
both copies of the Prdx1 gene. (B) MECs (n¼3) were isolated from MMTV-v-H-Ras mice/Prdx1
 /  or MMTV-v-H-Ras mice/Prdx1
þ/þ and
analysed on a non-reducing SDS–PAGE for PTEN oxidation as described above. Statistical analysis of PTEN oxidation was done using a w
2 test.
(C) The same protein lysates were also analysed for Akt phosphorylation on Ser473, as described above. *Non-statistically signiﬁcant.
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2006). Such short time of membrane binding could explain
why we (Figure 2B, C, E and F; Supplementary Figure S2B
and D) and others see only small amounts of PTEN oxidized
after cell exposure to H2O2 or PDGF (Kwon et al, 2004).
PDGF-induced H2O2 stems either from metabolized
superoxide released by NADPH oxidases (NOXs) or the
mitochondria and is considered a signalling molecule
(Rhee, 2006). As discussed earlier (Leslie et al, 2003),
such ﬁnding may be attributed to the proximity of NOXs
complexes and PIP3. Over-expression of Nox1, in PDGF-
stimulated NIH 3T3 cells rapidly increases PIP3 levels, in
contrast to PI3K activity, suggesting that Nox1-induced
superoxide enhances PIP3 levels by inactivating PTEN
rather than activating PI3K. Expression of a peroxidase
inactive Prdx2 leads to a rapid increase of PIP3 levels in
growth factor stimulated cells, which is reversed by
Prdx2
WT (Kwon et al, 2004). In our hands however, Prdx2
did not bind PTEN, as we were unable to detect an inter-
action of Prdx2 and PTEN by immunoprecipitation (data
not shown).
PTEN lipid phosphatase activity has an important function
in tumour suppression (Tolkacheva and Chan, 2000; Koul
et al, 2002) and Akt1 ablation protects (MMTV)-ErbB2/neu,
MMTV-polyoma middle T and MMTV-v-H-Ras mice from
breast cancer initiation (Skeen et al, 2006; Maroulakou
et al, 2007). Here, we show that loss of Prdx1 increased
basal, H2O2 and PDGF-induced Akt activity (Figure 2A, D and
G) and Prdx1 peroxidase activity was essential in suppres-
sing H-Rasv12 and ErbB-2/neuT-induced transformation
(Figure 1B; Supplementary Figure S5A). Along those lines,
Prdx1 ablation accelerated mammary tumorigenesis in
MMTV-v-H-Ras mice and increased levels of pAkt
Ser473 and
PTEN oxidation in MECs from these mice (Figure 6A–C).
Prdx1 tumour suppression seemed to occur largely via reg-
ulation of the PTEN and Akt. Knock down of Prdx1 in
PTEN
 / MEFs did not signiﬁcantly enhance H-Ras or ErbB-
2-induced transformation (Figure 5C and D), whereas
in transformed PTEN-containing MEFs, decrease in Prdx1
levels resulted in a gain of transformation: 1.5-fold for
H-RasV12 and only 1.35-fold for ErbB-2/neuT, which
we contributed to decreased Prdx1 knock down in
PTEN
 / ;shPrdx1;GFP PTEN;ErbB 2/neuTMEFs compared with
PTEN
 / ;shPrdx1;GFP PTEN;H RasV12MEFs). Lack of PTEN also
did not result in Prdx1 over-oxidation nor reduced expression
(Figure 5B and E), suggesting that in PTEN-deﬁcient cells,
Prdx1 is acting as peroxidase.
However, we have to consider the regulation of other
phosphatases or kinases by Prdx1 or H2O2 in Akt-driven
tumorigenesis. SHIP-1 and 2 are known to dephosphorylate
PIP3 to PtdIns (3,4)P2 (Vivanco and Sawyers, 2002).
However, SHIP2 is not inactivated by oxidative stress
(Leslie et al, 2003). PTEN
 / ;shPrdx1MEFs showed decreased
pAKT
Ser473 levels compared with PTEN
 / MEFs (Figure 5D),
perhaps due to the activation of SHIP2 by small amounts of
H2O2. However, H2O2 treatment of PTEN
 / ;shPrdx1MEFs in-
creased pAKT
Ser473 levels comparable to PTEN
 / MEFs, sug-
gesting maybe a H2O2-induced inactivation of PP2A (Rao and
Clayton, 2002), as loss of Prdx1 also inactivated PP2A activity
(Supplementary Figure 2E). We also cannot exclude a regula-
tion of PI3K by Prdx1, as H-Ras and ErbB-2/neuT trans-
formed Prdx1
 / MEFs display a lesser sensitivity
towards PI3K inhibitors (Table I; Supplementary Figure 5B),
compared with Prdx1
þ/þMEFs.
In summary, oxidative stress and carcinogenesis are
closely linked, however, molecular details, especially how
oxidative stress promotes pro-oncogenic signalling pathways
are scarce. Our studies shed some light on how H2O2 can
promote oncogenic Ras and ErbB-2 signalling by providing
evidence for the ﬁrst time that the tumour suppressive
function of PTEN and Prdx1 are closely related. The mechan-
istic details of the Prdx1 and PTEN interaction and its
regulation in terms of Prdx1 peroxidase activity and PTEN
oxidation will be important in future work.
Materials and methods
Reagents
All chemicals were purchased from Sigma Aldrich unless otherwise
indicated. Ly294002, WM, antibodies against PTEN (138G6), Akt
(11-E7), Akt-phosphoserine 473 (193H12), Akt-phosphothreonine
308 (244F9), phospho Akt substrate (110B7E) and HA-tag were
purchased from Cell Signaling; Antibodies recognizing PTEN
(A2B1), PTEN (N-19) and Actin (C-11) were purchased from Santa
Cruz; antibodies against Prdx1 and Prdx1-SO2/-SO3 were purchased
from Abcam; Ras antibody from Oncogene; ErbB-2 antibody from
Biosource. HA-conjugated agarose beads were purchased from
Roche. Amplex Red reagent: Molecular Probes. DMEM, FBS,
Glutamax, NEAA, Pen/Strep, Sodium Pyruvate, DMEM without
Phenol Red, PBS and PDGF stem from Invitrogen; GST-sepharose
from Pharmacia. 6His–PTEN was expressed in Escherichia coli BL21
from the fusion vector pProEx HTb PTEN and puriﬁed by standard
protocols.
Retrovirus
The retrovirus was generated after conducting a transient transfec-
tion of retroviral constructs into a 293T/17 (ATCC) ecotropic-
packaging cell line. Retroviral infection of MEFs was carried out for
4–6h in the presence of 8mg/ml polybrene. An antibiotic selection
was carried out 24h later until all uninfected cells were eliminated
and stable polyclonal cell lines were generated.
Generation of MEFs
MEFs were generated from Prdx1
þ/  littermate matings in a
C57BL/6J/129Sv background. Primary MEFs were harvested from
E13.5 embryos as described earlier (Neumann et al, 2003). Primary
Prdx1 and PTEN MEFs (passages 3–4) were immortalized by
retroviral infection with pBabe-hygro DD p53 expressing dominant-
negative p53 (Hahn et al, 2002) and selected with 150mg/ml
hygromycin for 14 days.
Amplex red assay
In total, 35000 MEFs were plated (n¼6) in 24-well plates (Costar
24) coated with ﬁbronectin. On the day of the assay, cells were
washed with PBS and repleted with serum-free and phenol red-free
DMEM medium. Amplex Red reagent and horse radish peroxidase
(HRP) were prepared as recommended by the manufacturer (HRP
0.2U/ml). MEFs were incubated with Amplex Red/HRP solution
at 371C before the ﬁrst reading (T0) at 540nm on a plate reader
(Molecular Devices SpectraMax M5). Plates were kept in an
incubator between readings. The resulting ﬂuorescence (FLU) was
compared with FLU from H2O2 standard curves and analysed.
Soft agar assays
P53DD-immortalized MEFs (Prdx1
 / , Prdx1
þ/þ) were infected
with retrovirus containing either Prdx1
WT or Prdx1
C172/51S, both
subcloned into pQCXI-puro (Clontech) and selected 10 days in
puromycin 2mg/ml. Some clones were further infected with a
retrovirus containing either H-Ras
V12 (pBabe-puro H-Ras
V12)( Y u
et al, 2001) or wild-type ErbB-2 (pBabe-puro ErbB-2) (Yu et al, 2001)
and selected in 5mg/ml puromycin for another 5 days. MEFs were
then resuspended in DMEM containing 0.53% agarose (Difco) and
plated onto a layer of 0.7% agarose-containing medium in 3.5-cm
plates in duplicate (10000 cells per plate). Colonies were counted
after 14–21 days.
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MEFs (1.8 10
5) were plated on 10-cm plates and serum-starved
(0.25% FBS) for 48h. Plates were then incubated with H2O2
(±Ly294002 or WM) as indicated. Akt and PTEN protein analysis
were done as described earlier (Leslie et al, 2003) with slight
modiﬁcations. Brieﬂy, lysis buffer (50mM Tris pH 7.4; 1% Triton
100; 0.5mM EDTA; 0.5mM EGTA; 150mM NaCl; 10% Glycerol;
50mM NaF; 100mM NaVO4; 40mM b-Glycerophosphate) was
degassed with Argon for 20min before adding 1% TritonX-100;
2mM PMSF; 5mg/ml Aprotinin; N-ethylmaleimide 40mM; and
bovine catalase 100mg/ml. Plates were transferred into an
anaerobic/argon cabinet and were washed twice with cold degassed
PBS. Cells were then scraped into lysis buffer and lysed on ice for
20min before conducting quantitative analysis as described above.
A measure of 65mg of protein were analysed under non-reducing
conditions with a 7.5% SDS–PAGE.
Co-immunoprecipitation
PTEN
WT (Addgene) was subcloned into a pQCXI vector (Clonetech) and
N-terminally tagged with Myc epitope. Prdx1
WT and Prdx1
C51/172S,
Prdx1
C51S, Prdx1
C172S (generated by site-speciﬁc mutagenesis) were
subcloned into a pCGN vector and N-terminally tagged with an HA
epitope. All constructs were transfected into 293T/17 (ATCC) cells
using Fugene transfection reagent (Roche). Cells were harvested
72h later for protein lysis under anaerobic conditions (as described
above). A measure of 1000mg protein was immunoprecipitated
using anti-HA afﬁnity matrix overnight at 41C before washing
four times with degassed lysis buffer before analysis on
4–12% gradient SDS–PAGE. Proteins were detected as described
above.
GST-pull down
BL21(DE3) were transformed and cultured overnight with pGEX-4T-
2 (Amersham) ligated earlier with Prdx1. At absorbance of 0.6–0.8
at 600nm, GST–Prdx1 expression was induced by the addition of
IPTG (200mM). Bacterial pellets were re-suspended using fusion
protein buffer containing 140mM NaCl, 10mM Na2HPO4, 1.8mM
KH2PO4, 2.7mM KCl, 1mM DTT, 50mM PMSF, 5mM benzamidine
hydrochloride hydrate and 3mM aprotinin. Lysate was then
sonicated and proteins were solubilized by the addition of Triton
X-100 (2%). After incubation of supernatant with glutathione
afﬁnity matrix, the matrix was washed consecutively with 500mM
NaCl, 50mM NaCl and the GST-tagged fusion protein was eluted
from the matrix by incubation with 30mM reduced glutathione. The
fusion protein was then desalted into 20mM Tris (pH 7.4) and
concentrated by centrifugation using a Centricon 30kD MWC ﬁlter
(Millipore, Bedford, MA). Incubations of equimolar concentrations
(100nM) of GST–Prdx1 plus His–PTEN or GST–EV (empty vector)
plus His–PTEN were performed in a buffer containing 20mM Hepes
(pH 8.0), 150mM NaCl, 2mM MgCl2,1 m MD T T ,5 0 mM PMSF,
5mM benzamidine hydrochloride, 3mM aprotinin and 1%Triton
X-100. Mixtures were allowed to incubate overnight at 41C before
pre-washed glutathione agarose beads were added. The retained
proteins were eluted from the resin by addition of 35mlo f
4  loading buffer and analysed by 10% SDS gels.
PTEN Plasmids
Different lengths of cDNA fragments encoding human PTEN amino
acids from 1–403 were subcloned from pSG5L HA–PTEN
WT
(Addgene#10750), pSG5L–HA–PTEN
C124S (#10745), pSG5L–HA–
PTEN
1 274 (#10740), pSG5L–HA–PTEN
1 373 (#10766), pSG5L–
HA–PTEN
D89–138 (#10924), pGEX2T–PTEN
D274–342 (#10739) (Ra-
maswamy et al, 1999) at restriction sites BamHI/EcoRI. A double-
stranded oligonucleotide encoding the Myc-tag sequence was
inserted 50 of the PTEN to generate Myc–PTEN. Inserts tagged with
Myc tag were cloned into pQCXIP to generate the corresponding
pQCXIP–Myc–PTEN plasmids; pQCXIP–MYC–PTEN
1 185 or
PTEN
1 351 or PTEN
186 351 or PTEN
D244 251 were generated by
PCR mutagenesis and conﬁrmed by DNA sequencing. Prdx1 N- and
C-terminal truncation mutants were generated by Bal31 nuclease
digest, ﬁll-in with T4-polymerase and subcloned into pCGN-HA.
Recombinant Prdx1 activity assay
Prdx1 peroxidase activity was studied by standard Trx/Trx
reductase (TrxR)/NADPH-coupled spectrophotometric assay as
described (Chae et al, 1994b). Brieﬂy, NADPH oxidation coupled
to the reduction of H2O2 was monitored at 371C as a decrease in
A340 using a SpectraMax M5 plate reading spectrophotometer. The
reaction was initiated by addition of the H2O2 (500mM) as a
substrate into a reaction mixture containing 50mM Hepes (pH 7.0),
0.15U TrxR, 18mM Trx, 25mM NADPH and 680nM Prdx1 (Sigma).
The effect of PTEN on Prdx1 activity was studied by titration of
reaction mixture with indicated increasing amount of PTEN (0.25–
1.25 PTEN/Prdx1mol/mol ratio). All experimental data were
normalized to initial (before addition of substrate) absorbency
and ﬁtted with linear regression (Sigma Plot 10, Systat Software,
Inc., San Jose, CA). Quality of ﬁt was controlled by regression
coefﬁcient (R
2X0.9).
PTEN inositol phosphatase activity
Myc–PTEN was expressed in 293T/17 cells in the presence or
absence of HA–Prdx1. Cells were lysed as described above in
phosphatase inhibitors free lysis buffer. PTEN proteins were
immunoprecipitated from lysates with anti-PTEN (Santa Cruz)
o/n as described above. IPs were then washed twice as described
(Schwartzbauer and Robbins, 2001), followed by a ﬁnal wash in
PTEN enzyme reaction buffer (10mM Hepes, 150mM NaCl, 10mM
DTT pH 7.2). The phosphatase reactions were done following
manufacturer’s instructions (Echelon Biosciences). Brieﬂy, the
immunoprecipitated PTEN proteins were incubated with PTEN
enzyme reaction buffer for an appropriate amount of time at 371Ci n
a 96-well plate coated with PI(3,4,5)P3. After removal of PTEN
proteins from plates, PI(4,5)P2 was determined according to the
manufacturer’s instructions. Absorbance was measured at 450nm
in a microplate reader, and PI(4,5)P2 produced was calculated from
a standard curve.
Recombinant PTEN inositol phosphatase activity
A measure of 20pmol puriﬁed recombinant human His–PTEN was
incubated with different amounts of Prdx1 (Sigma Aldrich) and
500mMH 2O2 in 20mM Tris–Cl (pH 7.4) buffer at room temperature
for 10min. H2O2 was removed by Bio-Gel P-6 chromatography
columns (Bio-Rad), following the manufacture’s instructions. The
protein mixture was then loaded onto PTEN activity assay plates as
described above (Echelon Biosciences). Equal amount of PTEN was
conﬁrmed by western blot with the PTEN antibody. For Prdx1
peptide interference, 20pmoles puriﬁed recombinant human His–
PTEN was pre-incubated with 20-fold excess amount of peptides on
ice in 20mM Tris–Cl (pH 7.4) (for Peptide 1 or scramble peptide 1)
or 0.2mM Tris–Cl (pH 7.4) (peptide 2 or scramble peptide 2) for 1h,
the unbound peptides were removed by Microcon Ultracel YM-10
ﬁlters following the manufacture’s instructions. The recovered
PTEN–peptide mixtures were then incubated with 20pmoles Prdx1
(Sigma Aldrich) and 500mMH 2O2 in 20mM Tris–Cl (pH 7.4) buffer
at room temperature for 10min and further processed as described
above. Peptide 1: MSSGNAKIGHPAPNFKATAVM; scrambled peptide 1:
KTHPMPSIAAKFNAGSNAMVG; Peptide 2: PAGWKPGSDTIKPDVQK
SKEYFSKQK; scrambled peptide 2: IKKSWKFGPGQPTSAPKQSKEV-
KYDD; all peptides had purity 475% and were purchased from
Genscript, NJ.
PTEN
 / MEFs experiments
An optimal sequence for knock down of Prdx1 by sh
(50-GCTCAGGATTATGGAGTCTTA-30) was identiﬁed from the TRC
consortium (http://www.broad.mit.edu) and was subcloned into
pMKO1 retroviral vector by AgeI/EcoRI digest. PTEN
 / MEFs were
infected with retroviral supernatant containing either pMKO1–
Prdx1shRNA or pMKO1 EV, and selected in puromycin 2mg/ml
for 1 week. GFP–PTEN was subcloned from pEGFP–C2–PTEN
(Leslie et al, 2000) into pQCXIP at restriction sites of AgeI-EcoRI.
PTEN
 / ;pMKO1MEFs or PTEN
 / ;shPrdx1MEFs were then transduced
with GFP–PTEN retrovirus and selected in 6mg/ml puromycin.
Infection and selection with retrovirus expressing either H-Ras
V12 or
ErbB-2/neuT was then challenged by 10mg/ml puromycin.
MMTV-v-H-Ras mice lacking Prdx1
MMTV-v-H-Ras mice (Sinn et al, 1987) were purchased from
Charles River. Prdx1
þ/ /MMTV-v-H-Ras mice were intercrossed to
generate Prdx1
 / /MMTV-v-H-Ras and Prdx1
þ/þ/MMTV-v-H-Ras
mice. Mice were monitored twice a week for tumour appearance.
Mouse mammary glands were isolated from age-matched 16-week-
old female MMTV-v-H-ras/Prdx1
 /  and MMTV-v-H-ras/Prdx1
þ/þ
(n¼3) mice following earlier described procedures (Fujiwara et al,
2005). Proteins were processed as described above.
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